DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)
January 20, 2023 at 10:52 am EST
Share
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
20.01.2023 / 16:50 CET/CEST
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
Title:
Dr.
First name:
Cord
Last name(s):
Dohrmann
2. Reason for the notification
a) Position / status
Position:
Member of the managing body
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Evotec SE
b) LEI
529900F9KI6OYITO9B12
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
Type:
Share
ISIN:
DE0005664809
b) Nature of the transaction
Purchase of shares by exercising stock options (Share Performance Plan)
Transaction linked to the exercise of share option programmes
c) Price(s) and volume(s)
Price(s)
Volume(s)
17.9445 EUR
110412.51 EUR
d) Aggregated information
Price
Aggregated volume
17.9445 EUR
110412.51 EUR
e) Date of the transaction
19/01/2023; UTC+1
f) Place of the transaction
Outside a trading venue
20.01.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women's health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
EVOTEC SE 
